Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Medical Equipment Industry Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies238
  • 7D1.7%
  • 3M1.2%
  • 1Y2.3%
  • YTD4.7%

In the last week, the Medical Equipment industry is up 1.7%, with Abbott Laboratories up 3.7%. Despite this gain, the industry's performance has been flat over the past year. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the U.S. Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 18 Nov 2025US$1.4tUS$297.7bUS$31.4b27.3x43.4x4.6x
Thu, 16 Oct 2025US$1.3tUS$293.3bUS$31.5b29.2x41.3x4.4x
Sat, 13 Sep 2025US$1.3tUS$292.5bUS$31.4b29.1x42.7x4.6x
Mon, 11 Aug 2025US$1.3tUS$291.8bUS$31.3b28x42.4x4.6x
Wed, 09 Jul 2025US$1.3tUS$286.7bUS$29.6b30.3x45.5x4.7x
Fri, 06 Jun 2025US$1.3tUS$286.7bUS$29.6b31.8x45.3x4.7x
Sun, 04 May 2025US$1.3tUS$285.7bUS$28.0b30.8x47.3x4.6x
Tue, 01 Apr 2025US$1.3tUS$283.2bUS$27.5b27.6x47.8x4.6x
Thu, 27 Feb 2025US$1.4tUS$282.9bUS$28.5b30.7x49.3x5x
Sat, 25 Jan 2025US$1.4tUS$285.2bUS$30.9b35.8x45.8x5x
Mon, 23 Dec 2024US$1.3tUS$284.0bUS$23.6b35.2x55.1x4.6x
Wed, 20 Nov 2024US$1.3tUS$283.1bUS$22.9b35.4x58.2x4.7x
Fri, 18 Oct 2024US$1.3tUS$279.9bUS$22.4b36.8x58.9x4.7x
Sun, 15 Sep 2024US$1.3tUS$279.6bUS$22.2b40.3x59.7x4.7x
Tue, 13 Aug 2024US$1.2tUS$279.6bUS$21.8b34.8x56.7x4.4x
Thu, 11 Jul 2024US$1.2tUS$276.4bUS$22.7b37.8x53.9x4.4x
Sat, 08 Jun 2024US$1.3tUS$276.4bUS$22.7b37.3x55.3x4.5x
Mon, 06 May 2024US$1.2tUS$276.8bUS$24.8b37.2x50.2x4.5x
Wed, 03 Apr 2024US$1.3tUS$274.1bUS$24.1b38.7x53.9x4.7x
Fri, 01 Mar 2024US$1.3tUS$265.8bUS$22.6b36.1x56.2x4.8x
Sun, 28 Jan 2024US$1.2tUS$268.0bUS$21.0b35.2x58.9x4.6x
Tue, 26 Dec 2023US$1.2tUS$267.4bUS$20.2b37.4x59.9x4.5x
Thu, 23 Nov 2023US$1.1tUS$267.4bUS$20.1b35.2x55.3x4.2x
Sat, 21 Oct 2023US$1.1tUS$263.8bUS$15.2b33.1x69.8x4x
Mon, 18 Sep 2023US$1.2tUS$263.8bUS$15.0b34.8x77.1x4.4x
Wed, 16 Aug 2023US$1.2tUS$263.4bUS$15.1b35.3x79.9x4.6x
Fri, 14 Jul 2023US$1.3tUS$260.7bUS$16.1b37.3x80x5x
Sun, 11 Jun 2023US$1.2tUS$261.2bUS$16.2b35.8x75.4x4.7x
Tue, 09 May 2023US$1.3tUS$260.5bUS$16.7b37.9x76x4.9x
Thu, 06 Apr 2023US$1.2tUS$260.2bUS$18.5b36.8x64.7x4.6x
Sat, 04 Mar 2023US$1.2tUS$260.2bUS$18.4b39.9x64.1x4.5x
Mon, 30 Jan 2023US$1.2tUS$261.3bUS$19.8b35x59.6x4.5x
Wed, 28 Dec 2022US$1.1tUS$243.2bUS$18.9b31.2x58.4x4.5x
Fri, 25 Nov 2022US$1.1tUS$244.3bUS$19.1b33x57.7x4.5x
Price to Earnings Ratio

57.7x


Total Market Cap: US$1.1tTotal Earnings: US$19.1bTotal Revenue: US$244.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Medical Equipment Industry Price to Earnings3Y Average 57.3x202320242025
Current Industry PE
  • Investors are pessimistic on the American Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 43.4x which is lower than its 3-year average PE of 57.3x.
  • The industry is trading close to its 3-year average PS ratio of 4.6x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 18% per year over the last three years.
  • Revenues for these companies have grown 6.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market-0.39%
Healthcare3.77%
Medical Equipment1.73%
Medical Supplies1.84%
Medical Equipment1.73%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 53.8x.
    • Analysts are expecting annual earnings growth of 12.4%, which is lower than the prior year's growth of 17.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 29% over the next 5 years.
  • This is better than its past earnings decline of 0.09% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABT Abbott LaboratoriesUS$130.593.7%
+US$8.2b		11.3%PE16.3x
MDT MedtronicUS$95.873.5%
+US$4.1b		9.5%PE26.4x
BDX Becton DickinsonUS$193.046.3%
+US$3.3b		-13.9%PE33x
SYK StrykerUS$362.222.0%
+US$2.8b		-7.0%PE47.1x
BSX Boston ScientificUS$102.691.8%
+US$2.6b		13.5%PE54.5x

Latest News

GEHC
US$70.63
GE HealthCare Technologies
7D
-3.9%
1Y
-14.6%
SOLV
US$76.19
Solventum
7D
6.1%
1Y
13.5%
RMD
US$244.71
ResMed
7D
-2.2%
1Y
2.2%
BDX
US$190.98
Becton Dickinson
7D
5.1%
1Y
-14.8%

Some Investors May Be Willing To Look Past Becton Dickinson's (NYSE:BDX) Soft Earnings

Nov 16
Some Investors May Be Willing To Look Past Becton Dickinson's (NYSE:BDX) Soft Earnings
DXCM
US$58.49
DexCom
7D
6.7%
1Y
-23.3%

DXCM: Share Recovery Likely With Positive Setup Expected For 2026

Analysts have lowered their price targets for DexCom, reducing the fair value estimate from $98.40 to $84.96. This reflects a reaction to recent conservative guidance, weaker growth outlook, and updated margin expectations.
BLCO
US$15.00
Bausch + Lomb
7D
-6.1%
1Y
-24.1%
ABT
US$130.03
Abbott Laboratories
7D
3.3%
1Y
10.8%

ABT: Momentum From Legal Win And Product Approvals Will Support Future Gains

Analysts have modestly revised their price targets for Abbott Laboratories, with recent updates ranging from $142 to $146 per share. They cite strong momentum in Medical Devices and a resilient, diversified business model, despite varied performance across business segments.
STE
US$257.01
STERIS
7D
-2.7%
1Y
18.4%
ISRG
US$546.71
Intuitive Surgical
7D
-5.1%
1Y
2.8%
GMED
US$83.64
Globus Medical
7D
-3.1%
1Y
2.2%
IDXX
US$669.00
IDEXX Laboratories
7D
-5.7%
1Y
59.4%
PODD
US$328.02
Insulet
7D
2.4%
1Y
25.8%

Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nov 09
Insulet Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
SYK
US$360.13
Stryker
7D
1.4%
1Y
-7.5%
MDT
US$96.28
Medtronic
7D
3.9%
1Y
9.9%

MDT: Focus Will Shift To Board Changes And New Committee Impact

Medtronic's analyst price target has recently increased, with updated targets rising as high as $115. This reflects analysts' growing optimism about the company due to anticipated revenue growth, positive investor engagement, and confidence in its product pipeline and execution.
ALGN
US$132.61
Align Technology
7D
-4.1%
1Y
-42.3%

ALGN: Volume Upside and Margin Strength Will Drive a Positive Outlook

Analysts have increased their price target for Align Technology from $175.07 to $180.50, citing improved revenue growth prospects, a stronger profit margin outlook, and management's recent success in delivering volume upside despite concerns about seasonality. Analyst Commentary Recent analyst updates on Align Technology reflect a range of perspectives, highlighting both positive developments and ongoing concerns in the company's outlook.
BSX
US$101.76
Boston Scientific
7D
0.8%
1Y
12.5%

BSX: Shares Will See Momentum From Recent Acquisition And Execution Confidence

Boston Scientific's analyst price target has been increased modestly, with the consensus now reflecting a higher fair value in addition to ongoing confidence in robust growth prospects and recent business performance, as analysts cite solid quarterly results, improving guidance, and successful strategic acquisitions. Analyst Commentary Recent analyst research on Boston Scientific highlights both optimistic and cautious perspectives regarding the company's valuation, strategic moves, and long-term growth outlook.